The National Institutes of Health renews its funding of a promising internship program at the Gladstone Institutes
Gladstone and Google AI collaborate to uncover the tip of an iceberg that could transform biomedical science
New insights into how a gene causes damage could impact future drug development
Gladstone launches the new Institute of Data Science and Biotechnology
Scientists examine the fastest changing regions in the human genome to learn how our species evolved.
Activating a single gene is sufficient to change skin cells into stem cells.
The discovery could improve treatments for autoimmune diseases and cancer
Simon takes on a central role in shaping Gladstone's future
Studer was selected for his groundbreaking research in stem cell-based therapies for Parkinson's disease
Deepak Srivastava, MD, led a team who created mouse models of CAVD that may be used to test drug therapies for the disease.
Scientists discover an enzyme that that could be targeted to treat both Alzheimer's disease and frontotemporal dementia.
Melton pioneered methods to treat diabetes with stem cells
A long time supporter of the Institutes, Price is the sixth trustee in Gladstone's 37-year history